These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23230717)

  • 1. [The influence of rotavirus vaccinations on the risk of gastrointestinal infections in children. Methods and preliminary results].
    Mrozek-Budzyn D; Agnieszka K; Majewska R; Augustyniak M
    Przegl Epidemiol; 2012; 66(3):459-64. PubMed ID: 23230717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiological situation of children' intestinal infections in Malopolska Voivodeship regarding to new possibilities of rotavirus prevention].
    Mrozek-Budzyn D
    Przegl Epidemiol; 2011; 65(4):561-6. PubMed ID: 22390039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
    Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RotaTeq vaccine adverse events and policy considerations.
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2008 Mar; 14(3):PH9-16. PubMed ID: 18301365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community.
    Muhsen K; Chodick G; Goren S; Shalev V; Cohen D
    Vaccine; 2010 Dec; 29(1):91-4. PubMed ID: 20969927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RotaTeq: Progress toward developing world access.
    Goveia MG; Nelson CB; Ciarlet M
    J Infect Dis; 2010 Sep; 202 Suppl():S87-92. PubMed ID: 20684723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents.
    Eberly MD; Gorman GH; Eide MB; Olsen CH; Rajnik M
    Vaccine; 2011 Jan; 29(4):650-9. PubMed ID: 21129394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.
    Weycker D; Sofrygin O; Kemner JE; Pelton SI; Oster G
    Vaccine; 2009 Aug; 27(36):4930-7. PubMed ID: 19555715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.
    Madhi SA; Kirsten M; Louw C; Bos P; Aspinall S; Bouckenooghe A; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A44-51. PubMed ID: 22520136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
    Clarke MF; Davidson GP; Gold MS; Marshall HS
    Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.
    Adlhoch C; Hoehne M; Littmann M; Marques AM; Lerche A; Dehnert M; Eckmanns T; Wichmann O; Koch J
    Pediatr Infect Dis J; 2013 Feb; 32(2):e82-9. PubMed ID: 23334342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
    De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
    Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh.
    Feller AJ; Zaman K; Lewis KD; Hossain I; Yunus M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A101-5. PubMed ID: 22520118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua.
    Orozco M; Vasquez J; Pedreira C; De Oliveira LH; Amador JJ; Malespin O; Andrus J; Tate J; Parashar U; Patel M
    J Infect Dis; 2009 Nov; 200 Suppl 1():S125-30. PubMed ID: 19821709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
    Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
    Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus gastroenteritis in uzbekistan: implications for vaccine policy in central Asia.
    Flem ET; Musabaev E; Juraev R; Kerin T; Gentsch J; Glass RI; Bresee JS
    J Infect Dis; 2009 Nov; 200 Suppl 1():S154-9. PubMed ID: 19817594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
    Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
    Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.